• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

The Column Group

edit

The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies

Recent Milestones

edit

• 
  The Column Group invested in Aragon Pharmaceuticals. (10/4/12)
  Posted 10/5/12 at 2:10am via prnewswire.com
• 
  The Column Group invested in Igenica. (6/12/12)
  Posted 6/12/12 at 6:45pm via finsmes.com
• 
  The Column Group invested in Peloton Therapeutics. (7/27/11)
  Posted 7/27/11 at 4:29am via finsmes.com
• 
  The Column Group invested in Cyterix Pharmaceuticals. (6/7/11)
  Posted 6/7/11 at 7:16pm via finsmes.com
• 
  The Column Group invested in Constellation Pharmaceuticals. (6/6/11)
  Posted 6/6/11 at 5:47pm via finsmes.com
• 
  The Column Group invested in Immune Design. (7/26/10)
  Posted 7/26/10 at 6:27pm via xconomy.com
• 
  The Column Group invested in Igenica. (6/14/10)
  Posted 6/14/10 at 6:53pm via onbiovc.com
• 
  The Column Group invested in Constellation Pharmaceuticals. (6/7/10)
  Posted 6/2/10 at 6:47pm via onbiovc.com
• 
  The Column Group invested in Aragon Pharmaceuticals. (4/22/10)
  Posted 4/22/10 at 9:31am via fiercebiotech.com
• 
  The Column Group invested in PTC Therapeutics. (12/22/09)
  Posted 12/22/09 at 3:44pm via finsmes.com
• 
  The Column Group invested in Constellation Pharmaceuticals. (8/13/09)
  Posted 10/8/09 at 10:57pm via constellationpharma.com
• 
  The Column Group invested in 3-V Biosciences. (7/10/09)
  Posted 10/7/09 at 8:19pm via 3vbio.com
• 
  The Column Group invested in Aragon Pharmaceuticals. (5/27/09)
  Posted 6/17/09 at 1:23pm via onbiovc.com
• 
  The Column Group invested in Immune Design. (7/7/08)
  Posted 7/26/10 at 6:27pm via xconomy.com
• 
  The Column Group invested in Vaccsys. (6/20/08)
  Posted 9/10/09 at 10:58pm via venturebeat.com
• 
  The Column Group invested in NGM Biopharmaceuticals. (2/1/08)
  Posted 6/18/09 at 6:09pm

Investments

Videos

Sources

1. SEC D (sec.gov) [edit]
2. Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers (prnewswire.com) [edit]
3. Igenica Raises $33M in Series C Funding (finsmes.com) [edit]
4. Peloton Therapeutics Completes $18M Series A Financing (finsmes.com) [edit]
5. Cyterix Pharmaceutics Raises $9.2M in Series A Financing (finsmes.com) [edit]
6. Constellation Pharmaceuticals Raises $15M in Series B Financing (finsmes.com) [edit]
7. Immune Design Nabs $32M for Targeted Vaccines (xconomy.com) [edit]
8. Igenica, Inc.: Series B $24M (onbiovc.com) [edit]
9. Constellation Pharmaceuticals, Inc.: Series B $4.8M (onbiovc.com) [edit]
10. Aragon Pharma readies first cancer trial after $22M B round (fiercebiotech.com) [edit]
11. PTC Therapeutics Raises 50M in Equity Financing (finsmes.com) [edit]
12. Constellation Pharmaceuticals, Inc. Closes $17 Million in Funding (constellationpharma.com) [edit]
13. 3-V Biosciences, Inc. Secures $30 Million in Series B Funding, Welcomes New Members to Board of Directors (3vbio.com) [edit]
14. Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]
15. Immune Design Aiming To Make Vaccines That Work Better in a Single Shot (xconomy.com) [edit]
16. Vaccsys raises $9 million for vaccine research (deals.venturebeat.com) [edit]
17. Capital Funding Report [edit]